BNC375 Alzheimer's Disease Drug Candidate Presented at Neuroscience Conference

Bionomics Limited today announced that new data on BNC375, its drug candidate with potential for the treatment of memory loss in Alzheimers Disease, will be presented at the 33rd Annual Meeting of the Australian Neuroscience Society taking place in Melbourne from 3 - 6 February 2013 at the Melbourne Convention Centre.

http://www.globenewswire.com/news-release/2013/02/04/520549/10020385/en/BNC375-Alzheimer-s-Disease-Drug-Candidate-Presented-at-Neuroscience-Conference.html